II. Development and future prospects of the third-generation EGFR-tyrosine kinase inhibitor

Shinya Sakata, Eiji Iwama, Isamu Okamoto

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish
    Pages (from-to)935-939
    Number of pages5
    JournalJapanese Journal of Cancer and Chemotherapy
    Issue number8
    Publication statusPublished - Aug 2015

    All Science Journal Classification (ASJC) codes

    • Oncology
    • Cancer Research

    Cite this